RT Journal Article
SR Electronic
T1 SARS-CoV-2 Load does not Predict Transmissibility in College Students
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.02.21252105
DO 10.1101/2021.03.02.21252105
A1 Di Tian
A1 Zhen Lin
A1 Ellie M. Kriner
A1 Dalton J. Esneault
A1 Jonathan Tran
A1 Julia C. DeVoto
A1 Naima Okami
A1 Rachel Greenberg
A1 Sarah Yanofsky
A1 Swarnamala Ratnayaka
A1 Nicholas Tran
A1 Maeghan Livaccari
A1 Marla Lampp
A1 Noel Wang
A1 Scott Tim
A1 Patrick Norton
A1 John Scott
A1 Tony Y. Hu
A1 Robert Garry
A1 Patrice Delafontaine
A1 Lee Hamm
A1 Xiao-Ming Yin
YR 2021
UL http://medrxiv.org/content/early/2021/03/05/2021.03.02.21252105.abstract
AB SARS-CoV2 is highly contagious and the global spread has caused significant medical, social and economic impacts. Other than vaccination, effective public health measures, including contact tracing, isolation and quarantine, is critical for deterring viral transmission, preventing infection progression and resuming normal activities. Viral transmission is affected by many factors but the viral load and vitality could be among the most important ones. Although in vitro culture studies have indicated that the amount of virus isolated from infected people determines the successful rate of virus isolation, whether the viral load carried at the individual level would affect the transmissibility was not known. We aimed to determine whether the Ct value, a measurement of viral load by RT-PCR assay, could differentiate the spreader from the non-spreader in a population of college students. Our results indicate that while at the population level the Ct value is lower, suggesting a higher viral load, in the symptomatic spreaders than the asymptomatic non-spreaders, there is a significant overlap in the Ct values between the two groups. Thus Ct values, or the viral load, at the individual level could not predict the transmissibility. Our studies also suggest that a sensitive method to detect the presence of virus is needed to identify asymptomatic persons who may carry a low viral load but can still be infectious.Competing Interest StatementThe authors have declared no competing interest.Funding StatementN/AAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The name of the institution body that ruled on ethics of our study is: Tulane Human Research Protection Office, Tulane University Biomedical Institutional Review Boards (IRB). The decision made is: "The activities described in the submission involve secondary, deidentified data therefore, the IRB determined that the activities are not human subjects research as defined by the Common Federal Rule. As such, IRB review and approval are not required."All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available within the article or its supplementary materials